IMPACT DX FACTOR V LEIDEN AND FACTOR II GENOTYPING TEST

System, Mass Spectrometry, Multiplex Genotyping, Hereditary Thrombophilia Related Mutations

SEQUENOM, INC.

The following data is part of a premarket notification filed by Sequenom, Inc. with the FDA for Impact Dx Factor V Leiden And Factor Ii Genotyping Test.

Pre-market Notification Details

Device IDK132978
510k NumberK132978
Device Name:IMPACT DX FACTOR V LEIDEN AND FACTOR II GENOTYPING TEST
ClassificationSystem, Mass Spectrometry, Multiplex Genotyping, Hereditary Thrombophilia Related Mutations
Applicant SEQUENOM, INC. 3595 JOHN HOPKINS COURT San Diego,  CA  92121
ContactRobin Weiner
CorrespondentRobin Weiner
SEQUENOM, INC. 3595 JOHN HOPKINS COURT San Diego,  CA  92121
Product CodePHJ  
CFR Regulation Number864.7280 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2013-09-23
Decision Date2014-06-13
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.